Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives
申请人:Cutarelli D. Timothy
公开号:US20080045718A1
公开(公告)日:2008-02-21
This application discloses a novel process to synthesize 2-(Quinolin-5yo)-4,5-Disubstituted-Azole derivatives, which may be used, for example, as PDE IV inhibitor compounds in pharmaceutical preparations.
[EN] "INHIBITORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, COMPOSITIONS, PRODUCTS AND USES THEREOF"<br/>[FR] "INHIBITEURS DE NICOTINAMIDE PHOSPHORIBOSYLTRANSFÉRASE, COMPOSITIONS, PRODUITS ET LEURS UTILISATIONS"
申请人:UNIVERSIT DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO
公开号:WO2014178001A1
公开(公告)日:2014-11-06
Compounds of formula (I): able to inhibit nicotinamide phosphoribosyltransferase. The disclosure also relates to the use of compounds of formula (I) for treatment of pathological conditions in which NAMPT inhibition might be beneficial, such as acute and chronic inflammation, cancer and metabolic disorders.
Deposition of SnS Thin Films from Sn(II) Thioamidate Precursors
作者:Amanda L. Catherall、Shasa Harris、Michael S. Hill、Andrew L. Johnson、Mary F. Mahon
DOI:10.1021/acs.cgd.7b01100
日期:2017.10.4
bis(2-methyl-N-(1-methylethyl)-propanethioamide)tin(II) has been determined through a single crystal X-ray diffraction analysis and shown to display a monomeric constitution in which the tin(II) center occupies a distorted pseudo square pyramidal geometry defined by the N2S2 donors and the stereochemically active lone pair. Both tin(II) derivatives have been assessed for their potential as single source
Methods and compositions are provided for forming complexes between dsDNA and novel DNA-binding polymers comprising N-terminal thiophene-containing moieties which exhibit selectivity for T-A base pairs. By appropriate choice of target sequences and DNA-binding polymers, complexes comprising polymer-DNA are obtained with high association constants. The formation of complexes can be used for identification of specific dsDNA sequences, for inhibiting gene transcription, and as a therapeutic for inhibiting proliferation of undesired cells or modulation of expression of specific genes.
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.